Skip to main content
. 2023 Mar 27;2(3):100629. doi: 10.1016/j.jscai.2023.100629

Table 2.

Angiographic characteristics

Acute coronary syndromes
Chronic coronary syndromes
Pa
All, N = 673 (809 lesions) Supreme DES, n = 441 (532 lesions) DP-EES, n = 232 (277 lesions) P All, N = 955 (1136 lesions) Supreme DES, n = 645 (751 lesions) DP-EES n = 310 (385 lesions) P
Stent implantation characteristics
 No. of stents per lesion 1.1 ± 0.3 1.1 ± 0.3 1.1 ± 0.3 .92 1.1 ± 0.3 1.1 ± 0.3 1.0 ± 0.2 .12 .43
 Stented lesion length, mm 22.26 ± 9.43 22.57 ± 9.65 21.66 ± 8.99 .12 22.14 ± 8.51 22.30 ± 8.67 21.81 ± 8.19 .22 .62
Maximum stent diameter, mm 2.97 ± 0.43 2.95 ± 0.42 3.00 ± 0.44 .24 2.91 ± 0.41 2.91 ± 0.41 2.91 ± 0.42 .61 .004
Procedural characteristics
 Fractional flow reserve 3.6% (30) 3.7% (20) 3.5% (10) .88 10.6% (123) 10.2% (78) 11.5% (45) .49 <.0001
 Intravascular ultrasound 8.4% (69) 8.9% (48) 7.3% (21) .44 20.0% (231) 19.9% (152) 20.2% (79) .89 <.0001
 Predilation 76.4% (630) 79.6% (429) 70.3% (201) .03 75.9% (887) 77.5% (593) 72.6% (284) .07 .80
 Postdilation 53.6% (440) 53.2% (285) 54.4% (155) .74 51.5% (591) 51.7% (393/760) 51.0% (198/388) .83 .35
Target vessel locationb
 Left anterior descending 43.3% (350) 44.5% (237) 40.8% (113) .18 46.0% (522) 45.9% (345) 46.0% (177) .94 .24
 Left circumflex 26.6% (215) 27.1% (144) 25.6% (71) .96 24.4% (227) 25.3% (190) 22.6% (87) .38 .28
 Right coronary 30.2% (244) 28.4% (151) 33.6% (93) .13 29.6% (236) 28.6% (215) 31.4% (121) .34 .77
 Left main 0.0% (0) 0.0% (0) 0.0% (0) NA 0.1% (1) 0.1% (1) 0.0% (0) 1.0 .98
ACC/AHA lesion class
 A 9.4% (76) 8.6% (46) 10.8% (30) .33 7.7% (88) 7.1% (53) 9.1% (35) .23 .20
 B1 26.3% (213) 24.4% (130) 30.0% (83) .11 24.5% (278) 25.8% (194) 21.8% (84) .14 .37
 B2 26.1% (211) 27.3% (145) 23.8% (66) .30 28.2% (320) 26.2% (197) 31.9% (123) .05 .32
 C 38.2% (309) 39.7% (211) 35.4% (98) .28 39.6% (450) 40.9% (307) 37.1% (143) .24 .53
 B2/C 64.3% (520) 66.9% (356) 59.2% (164) .04 67.8% (770) 67.1% (504) 69.1% (266) .50 .12
Calcification (moderate/severe) 30.9% (249/807) 31.7% (168/530) 29.2% (81) .56 36.5% (415) 37.0% (278) 35.6% (137) .77 .014
Any bifurcation 21.1% (171) 21.4% (114) 29.6% (57) .78 22.3% (253) 22.4% (168) 22.1% (85) .94 .55
Baseline QCA resultsb
 Reference diameter, mm 2.74 ± 0.45 2.72 ± 0.44 2.77 ± 0.47 .10 2.68 ± 0.48 2.69 ± 0.48 2.67 ± 0.47 .47 .01
 Minimal lumen diameter, mm 0.87 ± 0.38 0.85 ± 0.37 0.90 ± 0.40 .07 0.97 ± 0.39 0.98 ± 0.40 0.96 ± 0.39 .40 <.0001
 Percent diameter stenosis, % 68.02 ± 13.04 68.35 ± 12.97 67.37 ± 13.16 .31 63.63 ± 13.19 63.49 ± 13.19 63.92 ± 13.20 .68 <.0001
 Lesion length, mmc 15.22 ± 7.73 15.53 ± 8.16 14.64 ± 6.83 .16 15.06 ± 7.13 15.11 ± 7.10 14.95 ± 7.20 .73 .63
Final QCA resultb
 In-stent minimal lumen diameter, mmc 2.70 ± 0.40 2.68 ± 0.40 2.73 ± 0.40 .09 2.65 ± 0.40 2.65 ± 0.41 2.65 ± 0.38 .96 .012
 In-stent diameter stenosis, %c 7.99 ± 4.72 8.14 ± 4.97 7.70 ± 4.22 .20 8.38 ± 4.58 8.50 ± 4.34 8.14 ± 5.01 .21 .07
 In-stent acute gain, mmc 1.83 ± 0.46 1.83 ± 0.46 1.83 ± 0.47 .92 1.68 ± 0.45 1.67 ± 0.45 1.69 ± 0.44 .56 <.0001
 Segment minimal lumen diameter, mmd 2.59 ± 0.41 2.57 ± 0.40 2.64 ± 0.41 .03 2.55 ± 0.43 2.55 ± 0.43 2.54 ± 0.42 .74 .02
 Segment diameter stenosis, %d 9.65 ± 3.86 9.70 ± 3.89 9.55 ± 3.81 .66 10.06 ± 4.80 10.09 ± 4.86 10.00 ± 4.68 .75 .06
 Segment acute gain, mmd 1.72 ± 0.47 1.72 ± 0.48 1.73 ± 0.47 .69 1.57 ± 0.46 1.57 ± 0.46 1.58 ± 0.46 .82 <.0001

Values are given as mean ± standard deviation or % (n).

ACC, American College of Cardiology; AHA, American Heart Association; QCA, quantitative coronary angiography.

a

All patients with acute coronary syndromes (ACS) vs all patients with chronic coronary syndromes (CCS) regardless of stent.

b

The results reported based on the angiographic core laboratory analysis.

c

The total number of lesions was 802 for ACS and 1120 for CCS.

d

The total number of lesions was 804 for ACS and 1127 for CCS.